NanoEcho is developing a new technology for a rectal cancer diagnostic device with higher precision, making it possible to customize treatment for each individual. The imaging technology is based on a new diagnostic method called magnetomotive ultrasound, which combines magnetism with nanotechnology and ultrasound technology.
NanoEcho was founded in Lund, Sweden, in 2015. The company began a clinical development study at Sahlgrenska University Hospital in 2021. By connecting its SOLIDWORKS® product development data to the cloud with solutions from the 3DEXPERIENCE Works portfolio, NanoEcho is further accelerating development, and ultimately time to market, while meeting document control regulatory requirements for medical devices more efficiently and cost-effectively.